global insulin delivery devices market

Advancements in technology in devices is a crucial factor fueling growth of the
insulin delivery devices market
Insulin is a hormone made in the pancreas, which is vital in regulating blood glucose ranges.
Insulin plays a critical position in metabolism as the shortage of insulin manufacturing or lack of
ability to respond to insulin results in the development of diabetes. Human beings with kind 1
and kind 2 diabetes require taking insulin photographs externally as a way to prevent lengthytime period complications and to resource the body in processing glucose and avoiding
headaches associated with hyperglycemia. The most normally prescribed insulin’s for treatment
are synthetic insulin’s, which can be given through injection pen, syringe, insulin pumps and
different devices.
According to the centers for ailment control and Prevention (CDC), 2014, about 29.1 million
people in the U.S have diabetes with a healthcare burden of around US$ 245 Bn and with a
predicted 4.6–9.2% of pregnant girls laid low with gestational diabetes.
View sample and decide:
The global Insulin delivery devices market is predicted to reach USD 17.27 billion through 2023
from USD 12.32 billion in 2018, growing at a CAGR of 6.99% during the forecast period 20182023.
Drivers and Restraints:
Developing occurrence of obesity and diabetes across the globe stays the important thing
driving force to foster the market for insulin delivery devices. Technological advances in these
devices, coupled with rising patient awareness approximately diabetes care are predicted to be
a few more key elements conserving an effective impact available on the market growth.
Furthermore, difficulty and risks related to the delivery of insulin are also foreseen to restrain
the growth of insulin delivery devices market.
To know more read:
Geographic Segmentation
On the basis of the geographical vicinity, the worldwide insulin delivery devices market is
segmented as North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.
North America accounted for the biggest share of 40.5% of the worldwide insulin delivery
devices market in 2018, whereas Asia-Pacific is anticipated to grow at the very best CAGR of
9.10% at some stage in the forecast period 2018-2023.
Get your customized report:
The major share holders of the market include Becton, Dickinson and Company (U.S.), Sanofi
(France), Novo Nordisk A/S (Denmark), Julphar (U.A.E.), Eli Lilly and Company (U.S.), Biocon Ltd.
(India), Ypsomed AG (Switzerland), Wockhardt Ltd. (India), B. Braun Meselgen AG (Switzerland),
and Biodel Inc. (U.S.).
Scope of the report
The report offers a comprehensive analysis of the industry by providing the estimations of
market potential and forecasts with utmost granularity. Along this, the factors influential in
effecting the market dynamics and trends are discussed in detail at the product level. Further,
the performance of the market at the regional and country-level is assessed and the prospects
with high growth potential are identified and debated.
The key players in the industry are profiled providing insights on their financial performance,
market position and growth strategies. Comparative analysis on prime strategical activities of
the market players delineating the key developments like mergers & acquisitions,
collaborations and an evaluation of the competitive environment within the industry are
provided. The report also offers a broad outlook of the market along with recommendations
from industry experts on the opportunities for investment activity.
What else? Apart from the syndicated report, our in-house team has an expertise and
experience in designing custom reports to meet your specific research needs and assist you in
making well-informed decisions.
Contact Info:
Name: Mr. Abhishek Shukla
Email: [email protected]
Organization: MarketDataForecast™
Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626

Insulin Delivery Devices Market By Type (Insulin Syringes, Insulin Pens, Insulin Pumps), Application (Type I Diabetes & Type II Diabetes)